{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:47:33Z","timestamp":1761562053459,"version":"3.38.0"},"reference-count":140,"publisher":"SAGE Publications","issue":"6","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Womens Health (Lond Engl)"],"published-print":{"date-parts":[[2015,11]]},"abstract":"<jats:p> Minimally invasive surgical techniques compared with laparotomy offer the advantages of less intraoperative blood loss, shorter hospitalization, fewer wound complications and faster return to baseline activity for both hysterectomy and myomectomy. While morcellation allows for the laparoscopic removal of large specimens, it may result in intraperitoneal dissemination of benign disease or upstaging of occult malignancy leading to compromised survival. There has been heightened scrutiny over appropriate patient selection and preoperative assessment in light of recent warnings against power morcellation issued by the US FDA. This commentary therefore summarizes the magnitude of such risks associated with uterine morcellation, current national regulatory statements and potential merits of risk-reducing approaches such as contained morcellation. The importance of patient counseling is underscored. <\/jats:p>","DOI":"10.2217\/whe.15.63","type":"journal-article","created":{"date-parts":[[2015,12,17]],"date-time":"2015-12-17T09:51:10Z","timestamp":1450345870000},"page":"929-944","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":3,"title":["Risk, Risk Reduction and Management of Occult Malignancy Diagnosed after Uterine Morcellation: A Commentary"],"prefix":"10.1177","volume":"11","author":[{"given":"Sarah","family":"Lynam","sequence":"first","affiliation":[{"name":"Department of Obstetrics, Gynecology, & Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Young","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, & Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vadim","family":"Morozov","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, & Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD 21201, USA"},{"name":"Center of Excellence in Minimally Invasive Gynecology, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gautam","family":"Rao","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, & Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD 21201, USA"},{"name":"Division of Gynecologic Oncology, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dana M","family":"Roque","sequence":"additional","affiliation":[{"name":"Department of Obstetrics, Gynecology, & Reproductive Sciences, University of Maryland School of Medicine, Baltimore, MD 21201, USA"},{"name":"Division of Gynecologic Oncology, Greenebaum Cancer Center, University of Maryland School of Medicine, Baltimore, MD 21201, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2015,11,1]]},"reference":[{"key":"bibr1a-whe.15.63","unstructured":"Papers of special note have been highlighted as:"},{"key":"bibr2a-whe.15.63","unstructured":"of interest."},{"issue":"05","key":"bibr1-whe.15.63","first-page":"1","volume":"51","author":"Keshavarz H","year":"2002","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"bibr2-whe.15.63","unstructured":"CDC\/NCHS National Hospital Discharge Survey. Number of all-listed procedures for discharges from short-stay hospitals, by procedure, category, and sex: United States, 2010. www.cdc.gov."},{"key":"bibr3-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2003.99"},{"key":"bibr4-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318299a6cf"},{"key":"bibr5-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3552(97)80047-8"},{"key":"bibr6-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182a4ee4d"},{"key":"bibr7-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003677.pub4"},{"key":"bibr8-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2014.09.007"},{"key":"bibr9-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2007.01.013"},{"key":"bibr10-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2005.03.009"},{"key":"bibr11-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2007.05.012"},{"key":"bibr12-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2013.08.706"},{"key":"bibr13-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0412.2011.01196.x"},{"key":"bibr14-whe.15.63","unstructured":"Sobolewski CJ. Meeting Materials of the Obstetrics and Gynecology Devices Panel. Surgical treatment options for fibroids and their outcomes. www.fda.gov."},{"key":"bibr15-whe.15.63","first-page":"471","volume":"81","author":"Steiner RA","year":"2013","journal-title":"Obstet. Gynecol."},{"key":"bibr16-whe.15.63","unstructured":"Price V. Meeting material of the obstetrics and gynecology devices panel. regulation of laparoscopic power morcellators. www.fda.gov."},{"key":"bibr17-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2013.12.121"},{"key":"bibr18-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2014.05.010"},{"key":"bibr19-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2014.10.009"},{"key":"bibr22a-whe.15.63","unstructured":"The authors objectively characterize scatter properties associated with power morcellators, and quantify magnitude of tissue spread that may occur secondary to power morcellation."},{"key":"bibr20-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2013.12.003"},{"key":"bibr21-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2011.12.019"},{"key":"bibr22-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1999.5490"},{"key":"bibr23-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2011.05.095"},{"key":"bibr24-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0412.2012.01453.x"},{"key":"bibr25-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2012.08.345"},{"key":"bibr26-whe.15.63","first-page":"1125","volume":"102","author":"Sepilian V","year":"2003","journal-title":"Obstet. Gynecol."},{"key":"bibr27-whe.15.63","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2013.11.024","volume":"132","author":"Donnez O","year":"2014","journal-title":"Gynecol. Oncol."},{"key":"bibr28-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2007.07.004"},{"key":"bibr29-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e318180219b"},{"key":"bibr30-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1111\/aogs.12549"},{"key":"bibr31-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2004.09.007"},{"key":"bibr32-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1097\/00000478-199406000-00001"},{"key":"bibr33-whe.15.63","volume-title":"Principles and Practice of Gynecologic Oncology","author":"Sutton G","year":"2009","edition":"5"},{"key":"bibr34-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050058"},{"key":"bibr35-whe.15.63","doi-asserted-by":"crossref","first-page":"625","DOI":"10.47102\/annals-acadmedsg.V39N8p625","volume":"39","author":"Ng J","year":"2010","journal-title":"Ann. Acad. Med. Singapore"},{"key":"bibr36-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1097\/00006250-199406000-00023"},{"issue":"11","key":"bibr37-whe.15.63","first-page":"8136","volume":"7","author":"Dall'Asta A","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"bibr38-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2009.02.020"},{"key":"bibr39-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2015.01.007"},{"key":"bibr40-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0b013e32835af98d"},{"key":"bibr41-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.08.024"},{"key":"bibr42-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1067\/mob.2000.107335"},{"key":"bibr43-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1097\/SPV.0b013e31829ff5b8"},{"key":"bibr44-whe.15.63","unstructured":"National Comprehensive Cancer Care Network. Clinical Practice Guidelines: genetic\/familial high-risk assessment: colorectal. Version 2. 2014. www.nccn.org."},{"key":"bibr45-whe.15.63","first-page":"414","volume":"83","author":"Parker WH","year":"1994","journal-title":"Obstet. Gynecol."},{"key":"bibr46-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.051633798"},{"key":"bibr47-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.02.026"},{"key":"bibr48-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(90)91298-Q"},{"key":"bibr49-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(16)45789-4"},{"key":"bibr50-whe.15.63","unstructured":"Kosary CL. SEER monograph: cancer of the corpus uteri. www.igcs.org 942."},{"key":"bibr51-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2007.01.031"},{"key":"bibr52-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1111\/IGC.0b013e31819a1f8f"},{"key":"bibr53-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.gyobfe.2008.09.022"},{"key":"bibr54-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-012-2559-0"},{"key":"bibr55-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1159\/000010172"},{"key":"bibr56-whe.15.63","doi-asserted-by":"crossref","unstructured":"Ehdaivand S, Simon RA, Sung CJ,  Incidental gynecologic neoplasms in morcellated uterine specimens: a case series with follow up. Hum. Pathol., pii: S0046\u20138177 (2014).","DOI":"10.1016\/j.humpath.2014.07.018"},{"key":"bibr57-whe.15.63","unstructured":"Pritts EA. Meeting Materials of the Obstetrics and Gynecology Devices Panel. General public presenter. www.fda.gov."},{"key":"bibr58-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.2820710440"},{"key":"bibr59-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2008.11.027"},{"key":"bibr60-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3182a189ac"},{"key":"bibr61-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.9005"},{"key":"bibr65a-whe.15.63","unstructured":"The authors derive incidence of uterine cancer among a multi-institutional insurance database of over 232,000 women undergoing minimally invasive hysterectomy from 2006\u20132012. This is one of the larger databases published. Among the 36,470 women who underwent morcellation, there were 27 per 10,000 with occult malignancy."},{"key":"bibr62-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2005.09.042"},{"key":"bibr63-whe.15.63","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2006.7.4.281"},{"key":"bibr64-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1995.9965"},{"key":"bibr65-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1002\/jcu.20075"},{"key":"bibr66-whe.15.63","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.181.5.1811369"},{"key":"bibr67-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/S0015-0282(98)00193-9"},{"key":"bibr68-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.20207"},{"key":"bibr69-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-009-1471-x"},{"key":"bibr70-whe.15.63","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.06.1403"},{"key":"bibr71-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2013.12.028"},{"key":"bibr72-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-014-0324-5"},{"key":"bibr73-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2009.03.005"},{"key":"bibr74-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-013-2819-9"},{"key":"bibr75-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1159\/000294861"},{"issue":"5","key":"bibr76-whe.15.63","first-page":"718","volume":"47","author":"Takeuchi S","year":"1999","journal-title":"J. Japan. Assoc. Rural Med."},{"key":"bibr77-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1046\/j.1525-1438.2002.01086.x"},{"key":"bibr82a-whe.15.63","unstructured":"The authors described the relative improvements in preoperative discrimination of leiomyosarcomas from degenerating leiomyomas using MRI, versus gadolinium-enhanced MRI, versus gadolinium-enhanced MRI and serum biomarkers."},{"issue":"6","key":"bibr78-whe.15.63","first-page":"954","volume":"77","author":"Stovall TG","year":"1991","journal-title":"Obstet. Gynecol."},{"issue":"2","key":"bibr79-whe.15.63","first-page":"142","volume":"33","author":"Sany O","year":"2012","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"bibr80-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1007\/s00192-012-1694-2"},{"key":"bibr81-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2013.03.033"},{"key":"bibr82-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9378(12)90910-2"},{"issue":"2","key":"bibr83-whe.15.63","first-page":"149","volume":"7","author":"Van den Bosch T","year":"1998","journal-title":"Eur. J. Cancer Prev."},{"key":"bibr84-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2014.06.010"},{"key":"bibr85-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.tjog.2013.11.007"},{"key":"bibr86-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000448"},{"key":"bibr87-whe.15.63","unstructured":"Yustein R. Meeting Material of the Obstetrics and Gynecology Devices Panel. Additional data: power morcellators and specimen bags. www.fda.gov."},{"key":"bibr88-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1089\/end.1998.12.325"},{"key":"bibr89-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2004.02.017"},{"key":"bibr90-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2014.06.004"},{"key":"bibr91-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2011.03.042"},{"key":"bibr92-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000000421"},{"key":"bibr93-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2014.07.007"},{"key":"bibr94-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.05.023"},{"key":"bibr95-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1007\/s00464-014-3422-0"},{"key":"bibr96-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198612253152606"},{"key":"bibr97-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn386"},{"key":"bibr98-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1053\/ejso.1998.0634"},{"key":"bibr99-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2013.11.024"},{"key":"bibr105a-whe.15.63","unstructured":"The authors provide their retrospective experience with surgical re-exploration following morcellation of occult leiomyosarcoma and STUMP. They recommend all patients undergo formal staging for purposes of prognostication."},{"key":"bibr100-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.07.080"},{"key":"bibr101-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1111\/j.1525-1438.2007.01126.x"},{"key":"bibr108a-whe.15.63","unstructured":"In this retrospective case series, the authors outline their institutional experience with re-exploration after unanticipated finding of malignancy following morcellation following supracervical hysterectomy. They estimate that approximately 15% of patients who are re-explored by laparotomy with staging are upstaged."},{"key":"bibr102-whe.15.63","first-page":"845","volume":"71","author":"Berchuck A","year":"1988","journal-title":"Gynecol. Oncol."},{"key":"bibr103-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1006\/gyno.1998.5124"},{"key":"bibr104-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(52)90074-4"},{"key":"bibr105-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9378(82)90358-1"},{"issue":"2","key":"bibr106-whe.15.63","first-page":"206","volume":"30","author":"Comio G","year":"2009","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"bibr107-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2011.04.021"},{"key":"bibr115a-whe.15.63","unstructured":"The authors quantify the adverse effect of morcellation on otherwise early-stage uterine leiomyosarcoma using best available data."},{"key":"bibr108-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijgo.2007.04.020"},{"key":"bibr109-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1097\/PGP.0b013e3182107ecf"},{"key":"bibr110-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2014.08.781"},{"key":"bibr119a-whe.15.63","unstructured":"In this systematic review, the authors attempt to address whether (1) en bloc removal of an intact uterus improves recurrence rates and survival in instances of occult leiomyosarcoma and (2) to quantify differences in outcome between women with leiomyosarcoma who undergo morcellation by electromechnical versus other means. The analysis is restricted to patients undergoing hysterectomy for presumed uterine fibroids."},{"key":"bibr111-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.28844"},{"key":"bibr112-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-011-1751-y"},{"key":"bibr122a-whe.15.63","unstructured":"The authors quantify the adverse effect of morcellation on otherwise early-stage uterine endometrial stromal sarcomas using best available data."},{"issue":"3","key":"bibr113-whe.15.63","first-page":"237","volume":"24","author":"Morice P","year":"2003","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"bibr114-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2012.09.028"},{"key":"bibr115-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2011.10.012"},{"key":"bibr116-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1097\/00129689-200308000-00015"},{"key":"bibr117-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.3248"},{"key":"bibr118-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1097\/IGC.0b013e3182174609"},{"key":"bibr119-whe.15.63","doi-asserted-by":"publisher","DOI":"10.4293\/108680813X13693422519271"},{"key":"bibr120-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1089\/1092642041255423"},{"key":"bibr121-whe.15.63","unstructured":"Society of Gynecologic Oncologists. SGO position statement: morcellation. www.sgo.org."},{"key":"bibr122-whe.15.63","unstructured":"Jones CM. Meeting Material of the Obstetrics and Gynecology Devices Panel. Quantitative assessment of risks of uterine power morcellation. www.fda.gov."},{"key":"bibr123-whe.15.63","unstructured":"Food and Drug Administration. Laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication. www.fda.gov."},{"key":"bibr124-whe.15.63","unstructured":"Food and Drug Administration. UPDATED laparoscopic uterine power morcellation in hysterectomy and myomectomy: FDA safety communication. www.fda.gov."},{"key":"bibr125-whe.15.63","unstructured":"American Association of Gynecologic Laparoscopists. AAGL statement to the FDA on power morcellation. www.aagl.org\/."},{"key":"bibr126-whe.15.63","unstructured":"American College of Obstetricians and Gynecologists. www.acog.org."},{"key":"bibr127-whe.15.63","unstructured":"Society of Gynecologic Surgeons. Special report. https:\/\/sgs.memberclicks.net."},{"key":"bibr128-whe.15.63","unstructured":"American Urogynecologic Society. AUGS position statement: laparoscopic uterine power morcellation in hysterectomy and myomectomy FDA safety communication and ACOG special report. www.augs.org."},{"key":"bibr129-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmig.2015.01.017"},{"key":"bibr130-whe.15.63","doi-asserted-by":"publisher","DOI":"10.1093\/phr\/118.3.272"}],"container-title":["Women's Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/whe.15.63","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.2217\/whe.15.63","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.2217\/whe.15.63","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T05:48:35Z","timestamp":1741672115000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.2217\/whe.15.63"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":140,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.2217\/whe.15.63"],"URL":"https:\/\/doi.org\/10.2217\/whe.15.63","relation":{},"ISSN":["1745-5057","1745-5065"],"issn-type":[{"type":"print","value":"1745-5057"},{"type":"electronic","value":"1745-5065"}],"subject":[],"published":{"date-parts":[[2015,11]]}}}